Anna-Maria Larsson

Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study

Kristina Lång, Viktoria Josefsson, Anna-Maria Larsson et al. · The Lancet Oncology · 2023 · 434 citations · Full text

Artificial Intelligence, Engineering, Medical Imaging +12

Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients

Caroline Bergenfelz, Anna-Maria Larsson, Kristoffer von Stedingk et al. · PLoS ONE · 2015 · 145 citations · Full text

Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study

Veronica Hernström, Viktoria Josefsson, Hanna Sartor et al. · The Lancet Digital Health · 2025 · 73 citations · Full text

A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation

Henrik Frithiof, Charlotte Welinder, Anna-Maria Larsson et al. · Journal of Translational Medicine · 2015 · 27 citations · Full text

Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study

Fríða Björk Gunnarsdóttir, Pär‐Ola Bendahl, Alexandra Johansson et al. · Breast Cancer Research · 2023 · 21 citations · Full text